CJC-1295/Ipamorelin is a research peptide combination containing two synthetic compounds studied for their interactions with growth hormone signaling pathways. CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is a selective growth hormone secretagogue that has been investigated for its activity at the ghrelin/growth hormone secretagogue receptor (GHS-R).
In scientific research, the CJC-1295/Ipamorelin combination is studied to investigate growth hormone release, pituitary signaling, GH/IGF-1 axis activity, receptor-mediated signaling, and related endocrine and metabolic pathways. Combining the two compounds allows researchers to examine the interaction between distinct mechanisms involved in experimental growth hormone signaling.
Quantity: 10 mg total (5 mg CJC-1295 / 5 mg Ipamorelin)
Form: Lyophilized Peptide Blend
Research Use Only. Not for human consumption.
$59.99
In stock
At Bakersfield Aminos, we are committed to supplying researchers with high-quality peptide compounds designed to support accurate and reproducible laboratory investigations. BA-CJC/IPA 10 mg is a research peptide blend containing 5 mg CJC-1295 and 5 mg Ipamorelin, providing two compounds with distinct mechanisms of action for investigations involving growth hormone signaling, pituitary function, receptor activity, and the GH/IGF-1 axis.
BA-CJC/IPA combines CJC-1295, a synthetic growth hormone-releasing hormone (GHRH) analogue, with Ipamorelin, a selective growth hormone secretagogue. This combination allows researchers to investigate two separate signaling mechanisms involved in experimental growth hormone regulation within a single formulation.
The peptide components are manufactured using controlled peptide synthesis techniques and may be evaluated using analytical methods such as High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry. These methods help characterize peptide purity, molecular mass, and identity, with batch-specific analytical documentation providing the most relevant results for individual lots.
CJC-1295 is studied for its interaction with GHRH receptors and associated pituitary signaling pathways. Ipamorelin is investigated for its activity at the growth hormone secretagogue receptor (GHS-R), providing researchers with an additional mechanism through which experimental GH signaling can be examined.
Experimental investigations involving CJC-1295 and Ipamorelin have examined pathways associated with growth hormone secretion and downstream GH/IGF-1 signaling. The combination provides a useful research model for studying interactions between GHRH-mediated and ghrelin-receptor-mediated signaling pathways.
BA-CJC/IPA is supplied as a lyophilized peptide blend to support stability during appropriate storage and provide researchers with a consistent format for controlled laboratory preparation.
Each vial contains a standardized 1:1 ratio of CJC-1295 to Ipamorelin, with 5 mg of each peptide for a total peptide content of 10 mg. The standardized composition supports consistency across laboratory investigations.
BA-CJC/IPA is manufactured and prepared using controlled peptide production and quality procedures intended to support analytical quality, consistency, stability, and experimental reproducibility.
Our knowledgeable support team is available to assist with general product handling, storage recommendations, analytical documentation, and technical questions related to laboratory research applications.
For researchers requiring detailed information for experimental design, the following specifications apply to BA-CJC/IPA:
Product: BA-CJC/IPA
Total Peptide Content: 10 mg
CJC-1295 Content: 5 mg
Ipamorelin Content: 5 mg
Blend Ratio: 1:1
Form: Lyophilized Peptide Blend
Compound Type: Synthetic research peptides
CJC-1295 Research Class: GHRH analogue
Ipamorelin Research Class: Growth hormone secretagogue / GHS-R agonist
Research Areas: Growth hormone signaling, pituitary signaling, GHRH receptor activity, GHS-R activity, GH/IGF-1 axis research, and endocrine signaling
Purity: Refer to batch-specific analytical testing or Certificate of Analysis (COA)
Storage Conditions: Store according to the conditions specified on the product label or accompanying batch documentation. Protect from excessive heat, moisture, and light where applicable.
This product is strictly intended for laboratory research and development purposes only. It is not approved for human consumption, veterinary use, therapeutic applications, cosmetic use, diagnostic procedures, or any other clinical application.
CJC-1295 and Ipamorelin are investigational research peptides, and their toxicological, pharmacological, and physiological properties have not been fully characterized for all potential applications. This material should only be handled by qualified professionals trained in appropriate laboratory safety procedures and peptide handling practices.
Researchers utilize CJC-1295 and Ipamorelin in experimental settings to investigate mechanisms associated with growth hormone signaling, pituitary function, GHRH receptor activity, GHS-R signaling, and the GH/IGF-1 axis. References to these areas of research describe experimental applications and should not be interpreted as claims regarding safety, efficacy, diagnosis, prevention, or treatment of any disease or medical condition.
Any experimental use should be conducted according to established laboratory protocols, appropriate safety procedures, and applicable regulations.
Researchers and purchasers are solely responsible for complying with all applicable local, state, and federal laws and regulations governing the purchase, possession, storage, handling, and use of research compounds.
Bakersfield Aminos assumes no liability for misuse, improper handling, or application of this material outside legitimate laboratory research settings.
